Linjie Yu

321 ZhongShan Road
Nanjing, 210008, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 31 publications

Novel natural inhibitor Rubimaillin targets NLRP3 R167/Y381 to ameliorate inflammatory and neurodegenerative diseases.

Novel natural inhibitor Rubimaillin targets NLRP3 R167/Y381 to ameliorate inflammatory and neurodegenerative diseases.

Journal: Journal of ethnopharmacology

Published: May 19, 2026

Targeting of NLRP3 Gln624/Ser658 by Carabrone attenuates inflammatory diseases.

Targeting of NLRP3 Gln624/Ser658 by Carabrone attenuates inflammatory diseases.

Journal: European journal of pharmacology

Published: March 26, 2026

Neuromyelitis optica spectrum disorder with painful tonic spasms as the first symptom: a case report.

Neuromyelitis optica spectrum disorder with painful tonic spasms as the first symptom: a case report.

Journal: Frontiers in medicine

Published: February 20, 2026

Plasma extracellular vesicle proteins biomarker for cerebral small vessel disease related cognitive impairment.

Plasma extracellular vesicle proteins biomarker for cerebral small vessel disease related cognitive impairment.

Journal: Alzheimer's research & therapy

Published: January 16, 2026

Performance of plasma pTau217, pTau181 and their ratios to Aβ42 in detecting Aβ pathology using a China-developed direct chemiluminescence assay.

Performance of plasma pTau217, pTau181 and their ratios to Aβ42 in detecting Aβ pathology using a China-developed direct chemiluminescence assay.

Journal: Alzheimer's research & therapy

Published: August 20, 2025

Efficacy and safety of edaravone sublingual tablet for patients with cerebral small vessel disease-related cognitive impairment: study protocol for a multicentre, randomised, double-blind, placebo-controlled trial.

Efficacy and safety of edaravone sublingual tablet for patients with cerebral small vessel disease-related cognitive impairment: study protocol for a multicentre, randomised, double-blind, placebo-controlled trial.

Journal: Stroke and vascular neurology

Published: March 10, 2025

Multimodal magnetic resonance imaging analysis of early mild cognitive impairment.

Multimodal magnetic resonance imaging analysis of early mild cognitive impairment.

Journal: Journal of Alzheimer's disease : JAD

Published: March 04, 2025

Neuroprotective Effects of Eugenol Acetate Against Ischemic Stroke.

Neuroprotective Effects of Eugenol Acetate Against Ischemic Stroke.

Journal: Journal of inflammation research

Published: September 05, 2024

Enterprise stents for the treatment of symptomatic non-acute intracranial artery stenosis disease: safety and efficiency evaluation.

Enterprise stents for the treatment of symptomatic non-acute intracranial artery stenosis disease: safety and efficiency evaluation.

Journal: Neurological research

Published: April 01, 2024

Aberrant Energy Metabolism in Alzheimer's Disease.

Aberrant Energy Metabolism in Alzheimer's Disease.

Journal: Journal of translational internal medicine

Published: February 13, 2023

Wwl70-induced ABHD6 inhibition attenuates memory deficits and pathological phenotypes in APPswe/PS1dE9 mice.

Wwl70-induced ABHD6 inhibition attenuates memory deficits and pathological phenotypes in APPswe/PS1dE9 mice.

Journal: Pharmacological research

Published: December 06, 2022

MiR-431 attenuates synaptic plasticity and memory deficits in APPswe/PS1dE9 mice.

MiR-431 attenuates synaptic plasticity and memory deficits in APPswe/PS1dE9 mice.

Journal: JCI insight

Published: October 13, 2022

Showing 1-12 of 31

Last Updated: 09/26/2026